Table 1.
Seroprevalence of anti-VZV IgG in non-VarV-vaccinated participants.
| Age (Years), No. (%) |
Zhanjiang (n = 3194) |
Heyuan (n = 692) |
p Value |
|---|---|---|---|
| 0 | 131 (87.33) | 110 (92.44) | 0.173 |
| >0–5 | 5 (11.63) | 11 (22.00) | 0.186 |
| >5–10 | 11 (33.33) | 30 (42.86) | 0.357 |
| >10–20 | 59 (64.84) | 21 (67.74) | 0.769 |
| >20–30 | 417 (89.68) | 31 (93.94) | 0.626 |
| >30–40 | 332 (93.26) | 93 (92.08) | 0.682 |
| >40–50 | 112 (91.80) | 97 (96.04) | 0.194 |
| >50–60 | 176 (94.12) | 92 (93.88) | 0.935 |
| ≥60 | 1692 (96.80) | 87 (97.75) | 0.847 |
| Total | 2935 (91.89) 2862 * (89.61) |
572 (82.66) 634 * (91.62) |
0.621 |
* This number represents the age-adjusted overall anti-VZV IgG seropositivity.